Mission Creek Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.9M | Sell |
30,008
-444
| -1% | -$42.9K | 0.64% | 38 |
|
|
2025
Q1 | $3.36M | Sell |
30,452
-52
| -0.2% | -$5.75K | 0.82% | 32 |
|
|
2024
Q4 | $2.86M | Buy |
30,504
+14,422
| +90% | +$1.35M | 0.63% | 40 |
|
|
2024
Q3 | $3.18M | Sell |
16,082
-269
| -2% | -$53.1K | 0.74% | 35 |
|
|
2024
Q2 | $2.8M | Buy |
16,351
+4,173
| +34% | +$716K | 0.71% | 37 |
|
|
2024
Q1 | $2.22M | Buy |
12,178
+637
| +6% | +$116K | 0.58% | 48 |
|
|
2023
Q4 | $1.79M | Sell |
11,541
-82
| -0.7% | -$12.7K | 0.46% | 59 |
|
|
2023
Q3 | $1.73M | Sell |
11,623
-76
| -0.6% | -$11.3K | 0.58% | 51 |
|
|
2023
Q2 | $1.58M | Buy |
11,699
+1,251
| +12% | +$169K | 0.51% | 62 |
|
|
2023
Q1 | $1.67M | Buy |
10,448
+1,394
| +15% | +$222K | 0.57% | 60 |
|
|
2022
Q4 | $1.46M | Buy |
9,054
+158
| +2% | +$25.5K | 0.52% | 67 |
|
|
2022
Q3 | $1.19M | Buy |
8,896
+156
| +2% | +$20.9K | 0.45% | 77 |
|
|
2022
Q2 | $1.34M | Sell |
8,740
-27
| -0.3% | -$4.14K | 0.45% | 82 |
|
|
2022
Q1 | $1.42M | Buy |
8,767
+234
| +3% | +$37.9K | 0.38% | 90 |
|
|
2021
Q4 | $1.16M | Buy |
8,533
+92
| +1% | +$12.5K | 0.23% | 118 |
|
|
2021
Q3 | $911K | Sell |
8,441
-895
| -10% | -$96.6K | 0.17% | 134 |
|
|
2021
Q2 | $1.05M | Buy |
9,336
+1,234
| +15% | +$139K | 0.17% | 113 |
|
|
2021
Q1 | $877K | Buy |
8,102
+36
| +0.4% | +$3.9K | 0.13% | 114 |
|
|
2020
Q4 | $864K | Buy |
8,066
+631
| +8% | +$67.6K | 0.26% | 102 |
|
|
2020
Q3 | $651K | Buy |
7,435
+6
| +0.1% | +$525 | 0.26% | 108 |
|
|
2020
Q2 | $729K | Buy |
7,429
+1,196
| +19% | +$117K | 0.38% | 70 |
|
|
2020
Q1 | $475K | Sell |
6,233
-25
| -0.4% | -$1.91K | 0.26% | 89 |
|
|
2019
Q4 | $554K | Buy |
+6,258
| New | +$554K | 0.25% | 103 |
|